Order before 3pm, dispatched same day
Order before 3pm, dispatched same day Research Use Only
Pay by Card / Apple Pay
99% Purity Money Back Guarantee Retatrutide Now Available
Research ReferenceCompound CombinationsResearch Use Only

Research Compound Combinations:
The Pure Grade Labs Reference Guide

Scientific work often studies signalling compounds in more than one context. Researchers compare molecules with distinct receptor actions or overlapping biological pathways to better understand what each contributes to an experimental observation.

This reference introduces six combinations described in the Pure Grade Labs research catalogue. Each entry summarises the areas studied for its components and links directly to the related supplier listing. Evidence for one compound does not establish the safety or effectiveness of a combination.

For research purposes only · Not for human consumption

How to read this guide

Every entry identifies the research compounds, outlines the mechanisms being investigated, and discusses the published literature that gives those areas scientific context.

This is a research reference, not a preparation, dosing or administration protocol. Researchers should evaluate the original scientific studies and their limitations independently before designing any work.

Six areas of investigation

Research Combination Reference

01 / 06

Injury Recovery Research Combination

BPC-157TB-500Bacteriostatic Water

Mechanism rationale

BPC-157 has been investigated in preclinical injury models involving blood-vessel signalling, fibroblast activity and tissue organisation. Thymosin beta-4, the peptide associated with TB-500 research, is connected with actin dynamics, cell movement and wound-response processes.

These are not identical mechanisms. The research question is whether studying cellular migration and local tissue signalling together can reveal different aspects of a repair model.

Published research context

Experimental studies have examined BPC-157 in tendon and other tissue models, while thymosin beta-4 has a separate literature in cell migration, angiogenesis and regeneration. Much of this work is laboratory or animal research.

Results from separate experiments should not be treated as proof of a tested BPC-157/TB-500 combination or as evidence of clinical recovery benefits.

View this research combination
02 / 06

GH Axis Research Combination

CJC-1295Ipamorelin

Mechanism rationale

GHRH analogues are studied for their effects on the growth hormone-releasing hormone receptor. Ipamorelin belongs to a different class of secretagogues and activates the ghrelin-associated GHS-R1a receptor.

Because the receptors are different, endocrine researchers have examined how the two classes of signals interact within the pituitary growth hormone system.

Published research context

Work on CJC-1295 variants addresses growth hormone and IGF-1 signalling, while early ipamorelin studies explored receptor activity and hormonal selectivity. Results depend on the exact molecule and experimental design.

DAC-modified CJC-1295 is pharmacologically different from its non-DAC form. Findings for one formulation should not be transferred automatically to the other.

View this research combination
03 / 06

Body Composition Research Combination

AOD-9604HGH Fragment 176–191Bacteriostatic Water

Mechanism rationale

AOD-9604 and HGH Fragment 176–191 are related to the C-terminal region of human growth hormone, but their molecular structures are not identical. Both appear in investigations of fat-cell biology and lipid metabolism.

Comparing related peptide fragments can help researchers examine how small structural changes alter biochemical behaviour. Similarity of origin should not be mistaken for equal activity.

Published research context

Preclinical work and some clinical development programmes have explored AOD-9604 as a metabolic research compound. The evidence for HGH fragments and for their combined study is more limited and requires careful source review.

This category concerns experimental mechanisms, not demonstrated weight-loss results or a clinically validated pairing.

View this research combination
04 / 06

Metabolic Research Combination

AOD-9604Tesamorelin

Mechanism rationale

AOD-9604 is studied for pathways associated with lipid metabolism. Tesamorelin, by comparison, is a growth hormone-releasing hormone analogue that influences the pituitary growth hormone axis.

These differing points of action are of interest when analysing relationships between peripheral metabolic processes and endocrine signalling.

Published research context

Tesamorelin has human clinical evidence and an approved, narrowly defined medical indication involving excess abdominal fat in adults with HIV-associated lipodystrophy. That approval does not apply to AOD-9604 or to this proposed combination.

The suitability, effects and safety of the combined substances cannot be inferred simply by placing their independent research findings side by side.

View this research combination
05 / 06

Longevity & Cellular Research Combination

EpithalonGHK-CuMOTS-C

Mechanism rationale

These three compounds appear in different branches of cellular biology. Epithalon has been considered in studies of telomere-related processes; GHK-Cu in extracellular-matrix and tissue-response work; and MOTS-C in mitochondrial and metabolic signalling research.

Grouping them illustrates the breadth of questions that researchers ask about cellular maintenance, from genomic regulation to energy sensing.

Published research context

Laboratory and preclinical findings have generated interest in each molecule, but the strength and nature of the evidence vary considerably. A change in a cell marker is not equivalent to an increase in human lifespan.

The combination remains a theoretical research grouping rather than an established anti-ageing intervention or proven additive strategy.

View this research combination
06 / 06

Cognitive Research Combination

SelankSemax

Mechanism rationale

Selank and Semax are synthetic neuropeptides discussed in experimental neuropharmacology. Selank-related research includes neurotransmitter regulation and stress-response pathways, while Semax research has examined neurotrophic factors, including BDNF-related signalling.

Their different proposed activities create a basis for comparative questions about neuronal signalling, without establishing a benefit from using the compounds together.

Published research context

The literature includes laboratory research and studies reported largely in Russian and Eastern European scientific contexts. Study quality, reproducibility and relevance to broader populations require independent evaluation.

Neither the existence of research nor the combination of two research agents establishes a reliable improvement in memory, concentration or neurological health.

View this research combination
Important research information

A note on research protocol design

Research involving multiple compounds requires careful review of evidence relating to each one separately, including how studies define outcome measures, distinguish mechanisms and control for confounding factors.

A scientific rationale for investigating two pathways together does not demonstrate that a particular pairing produces an added effect. Protocol choices must be made by appropriately qualified researchers within applicable legal and institutional requirements.

No experimental amounts, routes of administration or schedules are provided in this guide.

Continue exploring

View our research compound combinations

Explore the six catalogue combinations and review the product information and available batch documentation through the linked listings.

Browse all stacks & bundles